Prosecution Insights
Last updated: November 04, 2026
Application No. 18/529,996

PRESSURIZED AEROSOL DEVICE FOR MEDICAL PROCEDURES

Final Rejection §102§103
Filed
Dec 05, 2023
Priority
Dec 05, 2022 — provisional 63/386,048
Examiner
HARRIS, WESLEY G
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Thermasolutions
OA Round
2 (Final)
74%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
545 granted / 741 resolved
+3.5% vs TC avg
Strong +22% interview lift
Without
With
+21.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 6m
Avg Prosecution
41 currently pending
Career history
800
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
36.8%
-3.2% vs TC avg
§102
22.9%
-17.1% vs TC avg
§112
36.4%
-3.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 741 resolved cases

Office Action

§102 §103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1, 3, 4, 8, 9, 11 and 13 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 6733479 B1 to Ott in view of US 20060184095 A1 to Ott (Ott ‘095). Regarding claim 1: Ott discloses: A spray device (figure 4) for delivering an aerosolized substance (column 9, lines 38-43) into a body cavity (6 as shown in figure 2), the spray device comprising: an elongate member (31) having a proximal portion (32), a distal portion (34), and a longitudinal axis (Ax) extending generally from the proximal portion (32) to the distal portion (34), the distal portion (34) being configured to be removably placed in the body cavity (column 2, lines 25-32), the elongate member (31) configured to receive a substance in a liquid form at the proximal portion (32) (liquid and gas can be received and then expelled as atomized liquid in a gas; column 9, lines 38-43), the elongate member (31) further configured to deliver the substance to the body cavity in an aerosolized form from the distal portion (34) (column 9, lines 38-43), the distal portion (34) comprising: one or more axial spray holes (36) configured to direct the substance from the distal portion (34) in a distal direction (as shown in figure 4); and at least two radial spray holes (see radial spray hole A in figure 1 below of 39) disposed at a first axial distance (as shown in figure 5) from a distal end (34) of the elongate member to form a first row of radial spray holes (as shown in figure 5), the first row of radial spray holes (see radial spray hole A in figure 1 below of 39) being configured to direct the substance from the distal portion in a radially outward direction (see F in figure 4), the at least two radial spray holes of the first row being spaced evenly about an outer surface of the elongate member (as shown in figure 5), at least two radial spray holes (see radial spray hole B in figure 1 below of 39) disposed at a second axial distance (as shown in figure 5) from the distal end (34) of the elongate member to form a second row of radial spray holes (as shown in figure 1 below), the second row of radial spray holes being configured to direct the substance from the distal portion in the radially outward direction (see F in figure 4), the at least two radial spray holes of the second row being spaced evenly about an outer surface of the elongate member (as shown in figure 5), the one or more axial spray holes (36) and the one or more radial spray holes (39) configured to cause the substance to exit from the distal portion (34) in the aerosolized form (column 9, lines 38-43). Ott fails to disclose: The radial spray holes of the second row being angularly offset from the radial spray holes of the first row. Ott ‘095 teaches: A spray device (figure 1) for delivering an aerosolized substance (¶0021) into a body cavity (13), the spray device comprising: at least two radial spray holes (see radial spray hole C in figure 2 below of 49) disposed at a first axial distance (see figure 2 below) and at least two radial spray holes (see radial spray hole D in figure 2 below of 49) disposed at a second axial distance (as shown in figure 2 below). Further, the radial spray holes at the first and second axial distance are angularly offset from each other (as shown in figure 2 below). The reference further teaches an embodiment where radial holes are angularly aligned (as shown in figure 1). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Ott to modify the radial spray holes at the first and second axial distance to be angularly offset from each other as taught by Ott ‘095. This is a simple substitution of one known element (radial spray holes at the first and second distance angularly aligned as disclosed in Ott) for another (radial spray holes at the first and second distance angularly offset as taught by Ott ‘095) to obtain predictable results (to spray the gas or liquid containing drugs into the body cavity). PNG media_image1.png 758 511 media_image1.png Greyscale Figure 1 – figure 5 of Ott, annotated by the examiner PNG media_image2.png 728 494 media_image2.png Greyscale Figure 2 – figures 3 and 3a of Ott ‘095, annotated by the examiner Regarding claim 3: Ott discloses: The spray device of claim 1 wherein the elongate member (31) has a generally round outer surface (as shown in figure 8a and 4), and wherein the at least two radial spray holes (39) of the first row and the at least two radial spray holes of the second row are evenly spaced about a circumference (as shown in figure 8a) of the distal portion (34) of the elongate member (31). Regarding claim 4: Ott discloses: The spray device of claim 1 wherein the one or more axial spray holes (36) and the one or more at least two radial spray holes (39) of the first row and the at least two radial spray holes of the second row (A and B in figure 1 above) are configured to cause the substance to exit from the distal portion in the aerosolized form (column 9, lines 38-43) when the substance is received at the proximal portion (32) in the liquid form at a flow rate of between 20 mL/min and 120 60mL/min (100 to 20000 ml (0.1 to 20 liters; column 1, lines 45-52)). Regarding claim 8: Ott discloses: The spray device of claim 1 wherein one axial spray hole (36) of the one or more axial spray holes is disposed at the distal end (as shown in figure 4) of the elongate member (31). Regarding claim 9: Ott discloses: The spray device of claim 1 wherein one axial spray hole (36) of the one or more axial spray holes is disposed proximal to (as shown in figure 4) the distal end (34) of the elongate member (31). Regarding claim 11: Ott discloses: The spray device of claim 1 wherein a number of radial spray holes in the first row is equal to a number of radial spray holes in the second row (as shown in figure 5 there are multiple rows of radial spray holes 39 which are equally spaced). Regarding claim 13: Ott discloses: The spray device of claim 1 wherein at least one of the at least two radial spray holes (74/39) of the first row of radial spray holes or the second row of radial spray holes (see figure 10c where the radial spray holes 74/39 can be arranged toward the proximal end) is angled towards the proximal portion (32) of the elongate member (31). Claim(s) 5, 6, and 12 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 6733479 B1 to Ott and US 20060184095 A1 to Ott (Ott ‘095) as applied to claims 3 and 11 above. Regarding claim 5: Ott discloses: The arrangement of the radial holes can vary based on the organs or other structures in the body cavity (column 6, lines 18-29). This teaches that the angle and the quantity of holes is a results effective variable dependent on the structures within the body cavity. Ott fails to disclose: The spray device of claim 3 wherein the elongate member comprises four radial spray holes in the first row spaced 90 degrees about the circumference of the distal portion of the elongate member and four radial spray holes in the second row spaced 90 degrees about the circumference of the distal portion of the elongate member. However, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the radial spray holes spacing to 90 degrees (4 holes in quantity for the radially holes at the first and second distance) about the circumference in order to avoid organs or structures within the body cavity since the spacing and quantity of the radial spray holes is a results effective variable as indicated above. Regarding claim 6: Ott discloses: The arrangement of the radial holes can vary based on the organs or other structures in the body cavity (column 6, lines 18-29). This teaches that the angle and the quantity of holes is a results effective variable dependent on the structures within the body cavity. Ott fails to disclose: The spray device of claim 3 wherein the elongate member comprises three radial spray holes in the first row spaced 120 degrees about the circumference of the distal portion of the elongate member and three radial spray holes in the second row spaced 120 degrees about the circumference of the distal portion of the elongate member. However, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the radial spray holes spacing to 120 degrees (3 holes in quantity for the radially holes at the first and second distance) about the circumference in order to avoid organs or structures within the body cavity since the spacing and quantity of the radial spray holes is a results effective variable as indicated above. Regarding claim 12: Ott discloses: The arrangement of the radial holes can vary based on the organs or other structures in the body cavity (column 6, lines 18-29). This teaches that the angle and the quantity of holes is a results effective variable dependent on the structures within the body cavity. Ott fails to disclose: The spray device of claim 11 wherein the first row comprises 4 radial spray holes and the second row comprises 4 radial spray holes, and wherein the 4 radial spray holes of the second row are angularly offset from the 4 radial spray holes of the first row by 45 degrees. However, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the radial spray holes spacing of the first and second row of holes to 45 degrees (4 holes in quantity) about the circumference in order to avoid organs or structures within the body cavity since the spacing and quantity of the radial spray holes is a results effective variable as indicated above. Allowable Subject Matter The following is a statement of reasons for the indication of allowable subject matter: claims 15-19 and 21-25 is/are allowed primarily because the prior art of record cannot anticipate Applicant' s claimed invention by a single reference nor render Applicant' s claimed invention obvious by the combination of more than one reference. Furthermore, the prior art of record does not teach “inserting a second trocar sleeve into the body cavity; and delivering an insufflation gas via the second trocar sleeve to form a hollow space in the body cavity” as within the context of the claimed invention as disclosed and within the context of the other limitations present in claim 15; and the prior art of record does not teach “a second trocar sleeve different from the first trocar sleeve, the second trocar sleeve adapted to be inserted into the body cavity; a supply of insufflation gas configured to be delivered to the body cavity via the second trocar sleeve to form a hollow space in the body cavity” as within the context of the claimed invention as disclosed and within the context of the other limitations present in claim 21. Therefore, the prior art of record cannot anticipate Applicant' s claimed invention by a single reference nor render Applicant' s claimed invention obvious by the combination of more than one reference. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Response to Arguments Applicant’s arguments, see remarks, filed 8/18/26, with respect to the rejection(s) of claim(s) 1, 3-6, 8, 9 and 11-3 under 35 USC 102 and 103 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of US 6733479 B1 to Ott and US 20060184095 A1 to Ott (Ott ‘095). Regarding 35 USC 112(b) claim rejections: The applicant’s amendments to the claims have addressed the previous claim rejections and for this reason they have been withdrawn. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WESLEY HARRIS whose telephone number is (571)272-3665. The examiner can normally be reached M to F, 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Tsai can be reached on (571) 270-5246. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WESLEY G HARRIS/Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Dec 05, 2023
Application Filed
May 18, 2026
Non-Final Rejection mailed — §102, §103
Aug 18, 2026
Response Filed
Sep 14, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779132
NEEDLE SHIELD REMOVER AND A MEDICAMENT DELIVERY DEVICE COMPRISING THE NEEDLE SHIELD REMOVER
2y 11m to grant Granted Nov 03, 2026
Patent 12773237
Surgical Instrument
3y 3m to grant Granted Oct 27, 2026
Patent 12773488
OPHTHALMIC SURGICAL CASSETTE
2y 3m to grant Granted Oct 27, 2026
Patent 12766248
DISPENSING DEVICE FOR WEARABLE DRUG DELIVERY DEVICE
4y 6m to grant Granted Oct 20, 2026
Patent 12765871
TREATMENT TOOL FOR ENDOSCOPE
3y 11m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
74%
Grant Probability
95%
With Interview (+21.6%)
2y 6m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 741 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month